Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
about
Rhizoma Pinelliae trypsin inhibitor separation, purification and inhibitory activity on the proliferation of BGC-823 gastric adenocarcinoma cells.Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors.Selective depletion of tumour suppressors Deleted in Colorectal Cancer (DCC) and neogenin by environmental and endogenous serine proteases: linking diet and cancerType II transmembrane serine proteases as potential targets for cancer therapy.Mechanisms of hepatocyte growth factor activation in cancer tissues.miR-221 and miR-222 synergistically regulate hepatocyte growth factor activator inhibitor type 1 to promote cell proliferation and migration in gastric cancer.The basal chorionic trophoblast cell layer: An emerging coordinator of placenta development.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation modelRegulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.Recombinant hepatocyte growth factor activator inhibitor 1: expression in Drosophila S2 cells, purification and crystallization.Expression of matriptase correlates with tumour progression and clinical prognosis in oral squamous cell carcinoma.Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/SPINT2 contributes to invasive growth of oral squamous cell carcinoma cells.
P2860
Q33769551-64A59250-9C0B-4CAA-90FF-A9995C9EB339Q35696184-40F5F3A0-6670-4C09-B9B8-3F4108C3F19FQ36156772-D1C1DBBE-6876-469C-9F30-1FBBC7556CA7Q37168351-9B81C7AA-1113-4F28-B203-81A950896665Q38255480-CC2BBD81-A854-44EC-B12B-3C0B2CC3EE61Q38670573-C28EF416-E341-4CC9-BDBE-6D540A90C4A4Q38700458-E87A805A-C214-4081-A1C2-491104693664Q38746986-43C34AA0-1A06-4811-A5A4-7A24673F269AQ38890925-8BA1BFAE-1EF7-49DA-B614-4B98C17F49B0Q39074016-75F19117-2C79-43EE-9321-3B177D85FDCFQ39224627-9ECCC74D-ACE6-46AB-BA7C-EF3BB4323DC0Q51221442-A4138F3B-6067-449A-A1A5-EB7EE781C0ECQ53075335-5E078546-FFC6-4AE4-B121-D593575F290EQ55343941-F112993B-B92A-44E1-9833-6FEE7DB59D0F
P2860
Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@en
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@nl
type
label
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@en
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@nl
prefLabel
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@en
Loss of membrane-bound serine ...... carcinoma cells' invasiveness.
@nl
P2093
P2860
P356
P1476
Loss of membrane-bound serine ...... carcinoma cells' invasiveness
@en
P2093
Chen-Yong Lin
Hiroaki Kataoka
Hiroshi Orikawa
Hiroyuki Tanaka
Kenji Yorita
Makiko Kawaguchi
Sumio Sakoda
Takashi Baba
P2860
P304
P356
10.1002/PATH.3993
P577
2012-04-18T00:00:00Z